These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 1384726)
1. The clinical relevance of salivary amylase monitoring in bulimia nervosa. Kronvall P; Fahy TA; Isaksson A; Theander S; Russell GF Biol Psychiatry; 1992 Jul; 32(2):156-63. PubMed ID: 1384726 [TBL] [Abstract][Full Text] [Related]
2. [Alpha-amylase isoenzymes in serum and saliva of patients with anorexia and bulimia nervosa]. Scheutzel P; Gerlach U Z Gastroenterol; 1991 Jul; 29(7):339-45. PubMed ID: 1950041 [TBL] [Abstract][Full Text] [Related]
3. Hyperamylasemia in bulimia nervosa. Walsh BT; Wong LM; Pesce MA; Hadigan CM; Bodourian SH J Clin Psychiatry; 1990 Sep; 51(9):373-7. PubMed ID: 1698766 [TBL] [Abstract][Full Text] [Related]
4. Hyperamylasemia in bulimia nervosa and hyperemesis gravidarum. Robertson C; Millar H Int J Eat Disord; 1999 Sep; 26(2):223-7. PubMed ID: 10422613 [TBL] [Abstract][Full Text] [Related]
13. Asymmetry of salivary cortisol and α-amylase responses to psychosocial stress in anorexia nervosa but not in bulimia nervosa. Monteleone P; Scognamiglio P; Canestrelli B; Serino I; Monteleone AM; Maj M Psychol Med; 2011 Sep; 41(9):1963-9. PubMed ID: 21284914 [TBL] [Abstract][Full Text] [Related]
14. Thirty-month outcome in patients with anorexia or bulimia nervosa and concomitant obsessive-compulsive disorder. Thiel A; Züger M; Jacoby GE; Schüssler G Am J Psychiatry; 1998 Feb; 155(2):244-9. PubMed ID: 9464205 [TBL] [Abstract][Full Text] [Related]
15. Suppression of eating by fenfluramine in patients with bulimia nervosa. Robinson PH; Checkley SA; Russell GF Br J Psychiatry; 1985 Feb; 146():169-76. PubMed ID: 3856458 [TBL] [Abstract][Full Text] [Related]
16. Dexamethasone suppression test using saliva cortisol measurement in bulimia nervosa. Neudeck P; Jacoby GE; Florin I Physiol Behav; 2001 Jan; 72(1-2):93-8. PubMed ID: 11239985 [TBL] [Abstract][Full Text] [Related]
17. [Prevalence of bulimia among secondary school students in Casablanca]. Ghazal N; Agoub M; Moussaoui D; Battas O Encephale; 2001; 27(4):338-42. PubMed ID: 11686055 [TBL] [Abstract][Full Text] [Related]
18. Hyperamylasemia and its relationship to binge-purge episodes: development of a clinically relevant laboratory test. Gwirtsman HE; Kaye WH; George DT; Carosella NW; Greene RC; Jimerson DC J Clin Psychiatry; 1989 Jun; 50(6):196-204. PubMed ID: 2470728 [TBL] [Abstract][Full Text] [Related]
19. Ipsapirone in the treatment of bulimia nervosa: an open pilot study. Geretsegger C; Greimel KV; Roed IS; Hesselink JM Int J Eat Disord; 1995 May; 17(4):359-63. PubMed ID: 7620475 [TBL] [Abstract][Full Text] [Related]
20. Symptom fluctuation in eating disorders: correlates of diagnostic crossover. Tozzi F; Thornton LM; Klump KL; Fichter MM; Halmi KA; Kaplan AS; Strober M; Woodside DB; Crow S; Mitchell J; Rotondo A; Mauri M; Cassano G; Keel P; Plotnicov KH; Pollice C; Lilenfeld LR; Berrettini WH; Bulik CM; Kaye WH Am J Psychiatry; 2005 Apr; 162(4):732-40. PubMed ID: 15800146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]